nRichDX at the AACR 2024 Annual Meeting
nRichDX exhibited at the American Association for Cancer Research Annual Meeting in San Diego, introducing new liquid biopsy sample preparation products and presenting collaborative research.
Liquid Biopsy Sample Preparation at AACR
The American Association for Cancer Research (AACR) 2024 Annual Meeting was held April 5-10, 2024 at the San Diego Convention Center in downtown San Diego, California.
nRichDX exhibited in booth #3721 from Sunday through Wednesday, April 7-10. Exhibits opened at 1:00 PM Pacific Time on Sunday, April 7 and closed at 12:30 PM on Wednesday, April 10.
Expanding Liquid Biopsy Sample Preparation
AACR 2024 marked the introduction of several new nRichDX instruments and kits for liquid biopsy applications.
New Instruments
nRichDX introduced new sample preparation instrumentation designed to expand automation and scalability for liquid biopsy applications.
New Kits
New kits were introduced to support higher-yield recovery of cfDNA, cfRNA, and circulating tumor cells.
Expanded Urine Input
The event materials highlighted urine sample processing of up to 50 mL in a single extraction.
Yield, Automation & Scalability
The new products were positioned around improving pre-analytical yield, automation, and scalability for liquid biopsy workflows.
Three Collaborative Posters at AACR 2024
Revolution Sample Prep System Research
nRichDX co-presented three posters featuring the Revolution Sample Prep System for liquid biopsy applications.
Enhancing urine-based cfDNA detection for prostate cancer diagnosis through increased urine input volume
Presented in collaboration with Agilent Technologies.
Urine as a non-invasive proxy for plasma in prostate cancer-related liquid biopsy applications
Presented in collaboration with OraSure Technologies' Novosanis Division.
Achieving sensitivity of 0.1% variant allele frequency (VAF) in plasma and urine with the nRichDX Revolution Sample Prep System evaluated on the MassARRAY system
Presented in collaboration with Agena Bioscience.
Explore the Research
Access nRichDX posters, publications, application notes, webinars, and additional liquid biopsy resources.
Recovering Rare Analytes for Downstream Assays
AACR attendees working on liquid biopsy tests and the extraction of cfDNA, cfRNA, circulating cell-free total nucleic acid (cfTNA), or the enrichment of circulating tumor cells were invited to visit the nRichDX booth and scientific posters.
The event materials highlighted the role of higher rare-analyte yields in supporting improved assay sensitivity and earlier detection of targeted oncology markers.
Urine sample volume highlighted in the AACR 2024 event materials for a single extraction.
- cfDNA
- cfRNA
- CTCs
- Urine
AACR 2024 has concluded.
Explore current nRichDX news, events, products, research, and liquid biopsy sample preparation resources.